19 June 2013
Keywords: profits, flat, novartis, despite, sales, growth, swiss
Article | 21 April 2003
Swiss drugmaker Novartis has reported a robust sales performance for thequarter ended March 31, but said that profits remained flat on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 April 2003
18 June 2013
© 2013 thepharmaletter.com